Keywords
Pandemic
Post-COVID syndrome
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To identify risk factors for persistence of symptoms one year after the diagnosis of SARS COV-2. Methods: This is a cohort study consisting of 379 participants who received a positive diagnosis by the molecular test PCR-RT for SARS-CoV-2, aged 18 years or older. A sociodemographic questionnaire was used, with symptomatic manifestations caused by COVID-19 and a sociodemographic questionnaire (gender, age, weight, height and whether physical activity is performed). For data analysis, the chi-square test and the application of the binary logistic regression model were used. The statistical significance adopted was 5%. Results: 56.7% (215) had at least one comorbidity. Of the total, 180 (47.5%) reported not practicing physical activity. The chance of a female person having persistent symptoms after one year was 2.33 CI 95% [1.48;3.66] compared to males and the chance of a person who does not practice physical activity to present PS after one year was 1.68 CI 95% [1.09:2.58] compared to people who practice physical activity. Conclusion: COVID-19 resulted in a clinical picture of persistent symptoms in 53.8% of patients, mainly in females. Not practicing physical activity was a risk factor for the presence of persistent symptoms.
References
ARAUJO GB, et al. Main risk factors identified in hospitalized cases for COVID-19 in the state of Paraná – Brazil. International Journal of Development Research, 2022; 12(08): 58071-58075.
ARAUJO GB, et al. Relação entre sobrepeso e obesidade e o desenvolvimento ou agravo de doenças crônicas não transmissíveis em adultos. Research, Society and Development, 2022; 11(2): e50311225917.
BRASIL. Coronavírus. Ministério da Saúde. 2020. Disponível em: https://www.coronavirus.saude.gov.br/.
CHANG AY, et al. The impact of novel coronavirus COVID‐19 on noncommunicable disease patients and health systems: a review. Journal of Internal Medicine, 2020; 289(4): 450–462.
COSTA REAR, et al. Principais correlações do tabagismo com a COVID-19. Research, Society and Development, 2020; 9(9): e84996981.
DAMIANO RF, et al. Post-COVID-19 psychiatric and cognitive morbidity: Preliminary findings from a Brazilian cohort study. General hospital psychiatry, 2022; 75: 38-45.
DE FIGUEIREDO BQ, et al. Mapeamento da “Covid longa” em pacientes assistidos pela USF Itamarati e previamente infectados por SARS-CoV-2. Research, Society and Development, 2021; 10(15): e512101523536.
DE MIRANDA DAP, et al. Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Transactions of The Royal Society of Tropical Medicine and Hygiene, 2022; 116(11): 1007-1014.
DE SABOIA TB e DA SILVA SFR. Síndrome da covid longa: uma revisão de literatura. Revista Multidisciplinar em Saúde, 2021; 2(4): 181-181.
DE SOUZA CEA, et al. Incidência da depressão em jovens durante o isolamento social. Research, Society and Development, 2022; 11(10): e303111032448.
FILLIS MMA, et al. Prevalência de sintomas persistentes em indivíduos infectados pelo novo coronavírus após 30 dias de diagnóstico. Revista de Saúde Pública do Paraná, 2021; 4(4): 44-60.
FRONTEIRA I. Observational studies in the era of evidence based medicine: short review on their relevance, taxonomy and designs. Acta medica portuguesa, 2013; 26(2).
GAIVA MAM. Imunização no contexto da Pandemia de COVID-19. Revista Nursing, 2021; 24(272): 5074.
HANSON SW, et al. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA, 2022; 328(16): 1604.
IMAMURA M, et al. Reabilitação ambulatorial da COVID longa: uma chamada à ação. Acta Fisiátrica, 2021; 28(4): 221-237.
ISER BPM, et al. Definição de caso suspeito da COVID-19: uma revisão narrativa dos sinais e sintomas mais frequentes entre os casos confirmados. Epidemiologia e Serviços de Saúde, 2020; 29.
MACHADO CJ, et al. Estimativas de impacto da COVID-19 na mortalidade de idosos institucionalizados no Brasil. Ciência & Saúde Coletiva, 2020; 25(9): 3437–3444.
MATHIEU E, et al. Coronavirus Pandemic (COVID-19). Our World in Data. Disponível em: <https://ourworldindata.org/covid-deaths>.
PEIXOTO SV, et al. Comportamentos em saúde e adoção de medidas de proteção individual durante a pandemia do novo coronavírus: iniciativa ELSI-COVID-19. Cadernos de Saúde Pública, 2020; 36.
RIBEIRO AC. Hipertensão arterial sistêmica como fator de risco para a forma grave da covid-19: revisão de escopo. Revista de Saúde Pública, 2022; 56.
SILVA LT, et al. Relação entre atividade física, COVID-19 e imunidade: Uma revisão de literatura. Research, Society and Development, 2021; 10(6): e11010615605.
SOUSA NETO AR, et al. Manifestações sintomáticas da doença causada por coronavírus (COVID-19) em adultos: revisão sistemática. Revista Gaúcha de Enfermagem, 2021; 42.
SYLVESTER SV, et al. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Current Medical Research and Opinion, 2022; 38(8): 1391-1399.
WU M. Síndrome pós-Covid-19 – Revisão de Literatura. Revista Biociências, 2021; 27(1): 1–14.
ZHU N, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, 2020; 382(8): 727–733.